Chronic Obstructive Pulmonary Disorder (COPD) Market Report

China Chronic Obstructive Pulmonary Disorder (COPD) Industry Market Research Report 2023-2029

  • POSTDATE：Sep 04, 2023
  • PAGES：233
  • REPORT CODE：GMM1775492
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Chronic Obstructive Pulmonary Disorder (COPD) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • AstraZeneca

    • Novartis AG

    • GlaxoSmithKline

    • Boehringer Ingelheim

    • Almirall

    • Abbott Laboratories

    • Astellas Pharma

    • Pfizer

    • Circassia Pharmaceuticals

    By Type:

    • Chronic Bronchitis

    • Emphysema

    By Application:

    • Hospitals and Clinics

    • Homecare Settings

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Chronic Obstructive Pulmonary Disorder (COPD) Market Overview 2018-2029

    • 1.1 China Chronic Obstructive Pulmonary Disorder (COPD) Industry Development Overview

    • 1.2 China Chronic Obstructive Pulmonary Disorder (COPD) Industry Development History

    • 1.3 China Chronic Obstructive Pulmonary Disorder (COPD) Industry Market Size (2018-2029)

    • 1.4 China Chronic Obstructive Pulmonary Disorder (COPD) Market Analysis by Type from Production Side

      • 1.4.1 China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume, Production Value and Growth Rate of Chronic Bronchitis (2018-2029)

      • 1.4.2 China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume, Production Value and Growth Rate of Emphysema (2018-2029)

    • 1.5 China Chronic Obstructive Pulmonary Disorder (COPD) Market Analysis by Application from Consumption End

      • 1.5.1 China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume, Sales Value and Growth Rate of Hospitals and Clinics (2018-2029)

      • 1.5.2 China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume, Sales Value and Growth Rate of Homecare Settings (2018-2029)

      • 1.5.3 China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Chronic Obstructive Pulmonary Disorder (COPD) Market Analysis by Region

      • 1.6.1 North China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Chronic Obstructive Pulmonary Disorder (COPD) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Chronic Obstructive Pulmonary Disorder (COPD) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Chronic Obstructive Pulmonary Disorder (COPD) Market Status and Competition Analysis in 2023

      • 2.2.3 China Chronic Obstructive Pulmonary Disorder (COPD) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Chronic Obstructive Pulmonary Disorder (COPD) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Chronic Obstructive Pulmonary Disorder (COPD) Industry Development

    Chapter 3 Chronic Obstructive Pulmonary Disorder (COPD)Industry Chain Analysis

    • 3.1 Chronic Obstructive Pulmonary Disorder (COPD) Industry Chain

    • 3.2 Chronic Obstructive Pulmonary Disorder (COPD) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Chronic Obstructive Pulmonary Disorder (COPD) Market

    • 3.3 Chronic Obstructive Pulmonary Disorder (COPD) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Chronic Obstructive Pulmonary Disorder (COPD) Market

    Chapter 4 China Chronic Obstructive Pulmonary Disorder (COPD) Market, by Type

    • 4.1 China Chronic Obstructive Pulmonary Disorder (COPD) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Chronic Obstructive Pulmonary Disorder (COPD) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume and Growth Rate, by Type

      • 4.5.1 China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume and Growth Rate of Chronic Bronchitis

      • 4.5.2 China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume and Growth Rate of Emphysema

    Chapter 5 China Chronic Obstructive Pulmonary Disorder (COPD) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Chronic Obstructive Pulmonary Disorder (COPD) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate, by Application

      • 5.5.1 China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate of Hospitals and Clinics

      • 5.5.2 China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate of Homecare Settings

      • 5.5.3 China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate of Others

    Chapter 6 China Chronic Obstructive Pulmonary Disorder (COPD) Market, by Region

    • 6.1 China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume and Production Value, by Region

    • 6.2 China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume and Sales Value, by Region

    Chapter 7 North China Chronic Obstructive Pulmonary Disorder (COPD) Market Analysis

    • 7.1 North China Chronic Obstructive Pulmonary Disorder (COPD) Market, by Type

    • 7.2 North China Chronic Obstructive Pulmonary Disorder (COPD) Market, by Application

    Chapter 8 Central China Chronic Obstructive Pulmonary Disorder (COPD) Market Analysis

    • 8.1 Central China Chronic Obstructive Pulmonary Disorder (COPD) Market, by Type

    • 8.2 Central China Chronic Obstructive Pulmonary Disorder (COPD) Market, by Application

    Chapter 9 South China Chronic Obstructive Pulmonary Disorder (COPD) Market Analysis

    • 9.1 South China Chronic Obstructive Pulmonary Disorder (COPD) Market, by Type

    • 9.2 South China Chronic Obstructive Pulmonary Disorder (COPD) Market, by Application

    Chapter 10 East China Chronic Obstructive Pulmonary Disorder (COPD) Market Analysis

    • 10.1 East China Chronic Obstructive Pulmonary Disorder (COPD) Market, by Type

    • 10.2 East China Chronic Obstructive Pulmonary Disorder (COPD) Market, by Application

    Chapter 11 Northeast China Chronic Obstructive Pulmonary Disorder (COPD) Market Analysis

    • 11.1 Northeast China Chronic Obstructive Pulmonary Disorder (COPD) Market, by Type

    • 11.2 Northeast China Chronic Obstructive Pulmonary Disorder (COPD) Market, by Application

    Chapter 12 Southwest China Chronic Obstructive Pulmonary Disorder (COPD) Market Analysis

    • 12.1 Southwest China Chronic Obstructive Pulmonary Disorder (COPD) Market, by Type

    • 12.2 Southwest China Chronic Obstructive Pulmonary Disorder (COPD) Market, by Application

    Chapter 13 Northwest China Chronic Obstructive Pulmonary Disorder (COPD) Market Analysis

    • 13.1 Northwest China Chronic Obstructive Pulmonary Disorder (COPD) Market, by Type

    • 13.2 Northwest China Chronic Obstructive Pulmonary Disorder (COPD) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 AstraZeneca

        • 14.1.1 AstraZeneca Company Profile

        • 14.1.2 AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Novartis AG

        • 14.2.1 Novartis AG Company Profile

        • 14.2.2 Novartis AG Chronic Obstructive Pulmonary Disorder (COPD) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 GlaxoSmithKline

        • 14.3.1 GlaxoSmithKline Company Profile

        • 14.3.2 GlaxoSmithKline Chronic Obstructive Pulmonary Disorder (COPD) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Boehringer Ingelheim

        • 14.4.1 Boehringer Ingelheim Company Profile

        • 14.4.2 Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Almirall

        • 14.5.1 Almirall Company Profile

        • 14.5.2 Almirall Chronic Obstructive Pulmonary Disorder (COPD) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Abbott Laboratories

        • 14.6.1 Abbott Laboratories Company Profile

        • 14.6.2 Abbott Laboratories Chronic Obstructive Pulmonary Disorder (COPD) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Astellas Pharma

        • 14.7.1 Astellas Pharma Company Profile

        • 14.7.2 Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Pfizer

        • 14.8.1 Pfizer Company Profile

        • 14.8.2 Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Circassia Pharmaceuticals

        • 14.9.1 Circassia Pharmaceuticals Company Profile

        • 14.9.2 Circassia Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Chronic Obstructive Pulmonary Disorder (COPD) Industry Research Conclusions

    • 15.2 Chronic Obstructive Pulmonary Disorder (COPD) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Industry Market Size (2018-2029)

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume, Production Value and Growth Rate of Chronic Bronchitis (2018-2029)

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume, Production Value and Growth Rate of Emphysema (2018-2029)

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume, Sales Value and Growth Rate of Hospitals and Clinics (2018-2029)

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume, Sales Value and Growth Rate of Homecare Settings (2018-2029)

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate from 2018-2029

    • Figure Central China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate from 2018-2029

    • Figure South China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate from 2018-2029

    • Figure East China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate from 2018-2029

    • Figure Chronic Obstructive Pulmonary Disorder (COPD) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type in 2018

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Type in 2023

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume and Growth Rate of Chronic Bronchitis (2018-2023)

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume and Growth Rate of Emphysema (2018-2023)

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application in 2018

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Market Share by Application in 2023

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Total Market Size and Growth Rate from Consumption End

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate of Hospitals and Clinics (2018-2023)

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate of Homecare Settings (2018-2023)

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Market Size and Growth Rate of Others (2018-2023)

    • Table China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume by Region (2018-2023)

    • Table China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume Share by Region (2018-2023)

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume Share by Region (2018-2023)

    • Table China Chronic Obstructive Pulmonary Disorder (COPD) Production Value by Region (2018-2023)

    • Table China Chronic Obstructive Pulmonary Disorder (COPD) Production Value Share by Region (2018-2023)

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Production Value Share by Region (2018-2023)

    • Table China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume by Region (2018-2023)

    • Table China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume Share by Region (2018-2023)

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume Share by Region (2018-2023)

    • Table China Chronic Obstructive Pulmonary Disorder (COPD) Sales Value by Region (2018-2023)

    • Table China Chronic Obstructive Pulmonary Disorder (COPD) Sales Value Share by Region (2018-2023)

    • Figure China Chronic Obstructive Pulmonary Disorder (COPD) Sales Value Share by Region (2018-2023)

    • Table North China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume by Type (2018-2023)

    • Table North China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume Share by Type (2018-2023)

    • Figure North China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume Share by Type (2018-2023)

    • Table North China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume by Application (2018-2023)

    • Table North China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume Share by Application (2018-2023)

    • Figure North China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume Share by Application (2018-2023)

    • Table Central China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume by Type (2018-2023)

    • Table Central China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume Share by Type (2018-2023)

    • Figure Central China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume Share by Type (2018-2023)

    • Table Central China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume by Application (2018-2023)

    • Table Central China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume Share by Application (2018-2023)

    • Figure Central China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume Share by Application (2018-2023)

    • Table South China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume by Type (2018-2023)

    • Table South China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume Share by Type (2018-2023)

    • Figure South China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume Share by Type (2018-2023)

    • Table South China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume by Application (2018-2023)

    • Table South China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume Share by Application (2018-2023)

    • Figure South China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume Share by Application (2018-2023)

    • Table East China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume by Type (2018-2023)

    • Table East China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume Share by Type (2018-2023)

    • Figure East China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume Share by Type (2018-2023)

    • Table East China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume by Application (2018-2023)

    • Table East China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume Share by Application (2018-2023)

    • Figure East China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume by Type (2018-2023)

    • Table Northeast China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume Share by Type (2018-2023)

    • Table Northeast China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume by Application (2018-2023)

    • Table Northeast China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume by Type (2018-2023)

    • Table Southwest China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume Share by Type (2018-2023)

    • Table Southwest China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume by Application (2018-2023)

    • Table Southwest China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume by Type (2018-2023)

    • Table Northwest China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Chronic Obstructive Pulmonary Disorder (COPD) Production Volume Share by Type (2018-2023)

    • Table Northwest China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume by Application (2018-2023)

    • Table Northwest China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Chronic Obstructive Pulmonary Disorder (COPD) Sales Volume Share by Application (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim Company Profile

    • Table Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Price and Gross (2018-2023)

    • Table Almirall Company Profile

    • Table Almirall Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Price and Gross (2018-2023)

    • Table Abbott Laboratories Company Profile

    • Table Abbott Laboratories Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Price and Gross (2018-2023)

    • Table Astellas Pharma Company Profile

    • Table Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Price and Gross (2018-2023)

    • Table Circassia Pharmaceuticals Company Profile

    • Table Circassia Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US